Information:
Fel:
ID
32977
Beskrivning
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01156597
Länk
https://clinicaltrials.gov/show/NCT01156597
Nyckelord
Versioner (1)
- 2018-11-22 2018-11-22 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
22 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes Mellitus NCT01156597
Eligibility Type 2 Diabetes Mellitus NCT01156597
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01156597
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Non-Insulin-Dependent Diabetes Mellitus WHO classification | Age
Item
type 2 diabetes, men and women, who criteria, aged 35-70 years
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C4267671 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Hemoglobin A1c measurement
Item
hba1c 7.5-10.0%
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
bmi 26-39 kg/m2
boolean
C1305855 (UMLS CUI [1])
Diet therapy | Sulfonylurea | Metformin
Item
either receiving dietary therapy only or monotherapy with either sulfonylurea or metformin
boolean
C0012159 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
C0038766 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
Patient is currently on a statin therapy
Item
already on statin therapy
boolean
C4316157 (UMLS CUI [1])
Cardiovascular Disease
Item
cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Kidney Disease
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Systemic disease
Item
other systemic disease
boolean
C0442893 (UMLS CUI [1])
Liver function tests abnormal | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
abnormal liver function tests (alt or ast>1.5 x uln)
boolean
C0151766 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
Uncontrolled hypertension | Blood pressure determination
Item
uncontrolled hypertension (bp >160/110)
boolean
C1868885 (UMLS CUI [1])
C0005824 (UMLS CUI [2])
C0005824 (UMLS CUI [2])
Triglycerides measurement
Item
triglyceride levels >400 mg/dl
boolean
C0202236 (UMLS CUI [1])
LIPID MODIFYING AGENTS | Fibrates | ezetimibe | Niacin | Bile acid sequestrants | Exception Statins
Item
lipid modifying drugs; fibrates, ezetimibe, niacin, bile sequestrants, but not statins (see below),
boolean
C3653535 (UMLS CUI [1])
C1449704 (UMLS CUI [2])
C1142985 (UMLS CUI [3])
C0027996 (UMLS CUI [4])
C2917337 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C0360714 (UMLS CUI [6,2])
C1449704 (UMLS CUI [2])
C1142985 (UMLS CUI [3])
C0027996 (UMLS CUI [4])
C2917337 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C0360714 (UMLS CUI [6,2])
Oestrogen therapy | Thyroid Diseases
Item
estrogen treatment or thyroid disease
boolean
C0279494 (UMLS CUI [1])
C0040128 (UMLS CUI [2])
C0040128 (UMLS CUI [2])
Mental condition | Substance Use Disorders
Item
psychiatric condition or substance abuse
boolean
C3840291 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0038586 (UMLS CUI [2])